Harrow, Inc. (HROW)

40.22 +1.43 (+3.69%) USD  |  NASDAQ  |  Apr 16, 09:38
More

Harrow Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for HROW.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Esperion Therapeutics, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Theravance Biopharma, Inc. Upgrade
Rhythm Pharmaceuticals, Inc. Upgrade